Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

about

Conditional, Genetically Encoded, Small Molecule-Regulated Inhibition of NFκB Signaling in RPE Cells.Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.

P2860

Q41483603-0C61FCCE-95B1-4299-9898-0A57C58AD420 Q55012033-7277DAA0-C315-4F1D-9FB9-4A33B522B0FC

P2860

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

Item

http://www.wikidata.org/entity/Q37680056

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

@en

Ig-like domain 6 of VCAM-1 is ...... in TNFα-induced angiogenesis.

@nl

type

Item

label

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

@en

Ig-like domain 6 of VCAM-1 is ...... in TNFα-induced angiogenesis.

@nl

prefLabel

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

@en

Ig-like domain 6 of VCAM-1 is ...... in TNFα-induced angiogenesis.

@nl

P1476

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

@en

P2093

Aerin Yoon

http://www.w3.org/2001/XMLSchema#string

Chang Sik Park

http://www.w3.org/2001/XMLSchema#string

Hee-Jun Na

http://www.w3.org/2001/XMLSchema#string

Junho Chung

http://www.w3.org/2001/XMLSchema#string

Kangseung Lee

http://www.w3.org/2001/XMLSchema#string

Sukmook Lee

http://www.w3.org/2001/XMLSchema#string

Taek-Keun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.

Collapsin response mediator protein-2 inhibits neuronal phospholipase D(2) activity by direct interaction

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Basic and therapeutic aspects of angiogenesis

Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review

P2888

emm.2016.147

P304

e294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMM.2016.147

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28209985

http://www.w3.org/2001/XMLSchema#string

P932

5336558

http://www.w3.org/2001/XMLSchema#string

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

about

P2860

P2860

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932